These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7931857)

  • 21. Methadone dose for cocaine abuse.
    Stine SM; Burns B; Kosten T
    Am J Psychiatry; 1991 Sep; 148(9):1268. PubMed ID: 1883015
    [No Abstract]   [Full Text] [Related]  

  • 22. Buprenorphine treatment of cocaine abuse.
    Kosten TR; Morgan CJ; Kleber HD
    NIDA Res Monogr; 1989; 95():461. PubMed ID: 2641031
    [No Abstract]   [Full Text] [Related]  

  • 23. Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions.
    Condelli WS; Fairbank JA; Dennis ML; Rachal JV
    J Subst Abuse Treat; 1991; 8(4):203-12. PubMed ID: 1787544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methadone maintenance: high rate of other substance use disorders and relationship to psychiatric comorbidity.
    Brooner RK; Bigelow GE; Regier MW
    NIDA Res Monogr; 1989; 95():442. PubMed ID: 2641022
    [No Abstract]   [Full Text] [Related]  

  • 25. Desipramine treatment of cocaine dependence in methadone-maintained patients.
    Arndt IO; Dorozynsky L; Woody GE; McLellan AT; O'Brien CP
    Arch Gen Psychiatry; 1992 Nov; 49(11):888-93. PubMed ID: 1444727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations.
    Batki SL; Manfredi LB; Jacob P; Jones RT
    J Clin Psychopharmacol; 1993 Aug; 13(4):243-50. PubMed ID: 8376611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treating cocaine abusing methadone maintenance patients with desipramine.
    Kosten T; Gawin F; Schumann B
    NIDA Res Monogr; 1988; 81():237-41. PubMed ID: 3136366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative urine drug monitoring in methadone programs: potential clinical uses.
    McCarthy J
    J Psychoactive Drugs; 1994; 26(2):199-206. PubMed ID: 7931864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antecedents and consequences of cocaine abuse among opioid addicts. A 2.5-year follow-up.
    Kosten TR; Rounsaville BJ; Kleber HD
    J Nerv Ment Dis; 1988 Mar; 176(3):176-81. PubMed ID: 3343591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients.
    Margolin A; Avants SK; Kosten TR
    Am J Drug Alcohol Abuse; 1995 Nov; 21(4):469-81. PubMed ID: 8561098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and implications of multi-drug abuse in a population of methadone-maintained women.
    Leifer ED; Goldman J; Finnegan LP
    NIDA Res Monogr; 1983 Apr; 43():322-8. PubMed ID: 6410267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: familiarity and preference.
    Barnas C; Rossmann M; Roessler H; Riemer Y; Fleischhacker WW
    J Clin Psychopharmacol; 1992 Dec; 12(6):397-402. PubMed ID: 1361936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
    Kamal F; Flavin S; Campbell F; Behan C; Fagan J; Smyth R
    Ir Med J; 2007 Mar; 100(3):393-7. PubMed ID: 17491538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diminished illicit drug use as a consequence of long-term methadone maintenance.
    Gottheil E; Sterling RC; Weinstein SP
    J Addict Dis; 1993; 12(4):45-57. PubMed ID: 8292639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification.
    Masson CL; Barnett PG; Sees KL; Delucchi KL; Rosen A; Wong W; Hall SM
    Addiction; 2004 Jun; 99(6):718-26. PubMed ID: 15139870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacotherapies for adolescent substance use disorders.
    Simkin DR; Grenoble S
    Child Adolesc Psychiatr Clin N Am; 2010 Jul; 19(3):591-608. PubMed ID: 20682223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: implications for new approaches in harm reduction and care.
    Gervasoni JP; Balthasar H; Huissoud T; Jeannin A; Dubois-Arber F
    Int J Drug Policy; 2012 Jan; 23(1):33-6. PubMed ID: 21705205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of mental and physical health disorders among older methadone patients.
    Rosen D; Smith ML; Reynolds CF
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.